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Background and purpose — Patients developing postoperative 
acute kidney injury (AKI) are at risk of higher morbidity and 
mortality. In arthroplasty patients, many pre- and perioperative 
factors are associated with AKI but some of the risk factors are 
unclear. We report the incidence of postoperative AKI, the condi-
tions associated with it, and survival rates in AKI patients. 
Patients and methods — We obtained data from 20,575 con-
secutive hip or knee arthroplasties. Postoperative AKI, occur-
ring within 7 days after the operation, was defi ned using the risk, 
injury, failure, loss, and end-stage (RIFLE) criteria. We analyzed 
independent risk factors for AKI using binary logistic regression. 
In addition, we reviewed the records of AKI patients and per-
formed a survival analysis. 
Results — The AKI incidence was 3.3 per 1,000 operations. 
We found preoperative estimated glomerular fi ltration rate, ASA 
classifi cation, body mass index, and duration of operation to be 
independent risk factors for AKI. Infections, paralytic ileus, and 
cardiac causes were the predominant underlying conditions, 
whereas half of all AKI cases occurred without any clear underly-
ing condition. Survival rates were lower in AKI patients.
Interpretation — Supporting earlier results, existing renal 
insuffi ciency and patient-related characteristics were found to be 
associated with an increased risk of postoperative AKI. Further-
more, duration of operation was identifi ed as an independent risk 
factor. We suggest careful renal monitoring postoperatively for 
patients with these risk factors.
■
Acute kidney injury (AKI) affects 0.5–5.2% of joint replace-
ment recipients and it is an independent risk factor for chronic 
renal impairment, increased morbidity, and death (Ympa et al. 
2005, Jafari et al. 2010, Coca et al. 2012, Kimmel et al. 2014, 
Perregaard et al. 2016). AKI increases in-hospital mortality 
but the adverse effects of AKI can also occur late (Lafrance 
and Miller 2010). 
The preoperative risk factors associated with postoperative 
AKI in arthroplasty patients include elevated body mass index 
(BMI), diabetes mellitus, chronic obstructive pulmonary dis-
ease, liver disease, congestive heart failure, hypertension, and 
vascular diseases (Jafari et al. 2010, Weingarten et al. 2012, 
Bell et al. 2015). Also, age, preoperative kidney dysfunction, 
and the preoperative use of renin-angiotensin axis-blocking 
medication are associated with postoperative AKI in arthro-
plasty patients (Aveline et al. 2009, Kimmel et al. 2014, 
Nielson et al. 2014, Bell et al. 2015). Although the American 
Society of Anesthesiologists’ (ASA) physical status classifi ca-
tion system has a connection with AKI in orthopedic patients 
(Bell et al. 2015), it is not associated with AKI in arthroplasty 
patients (Jafari et al. 2010, Kimmel et al. 2014).
Perioperative factors associated with AKI include general 
anesthesia and blood transfusions (Weingarten et al. 2012). 
Also, duration of operation has been reported to be longer in 
AKI patients, but not statistically signifi cantly so (Jafari et al. 
2010, Weingarten et al. 2012, and Kimmel et al. 2014). The 
effects of non-steroidal anti-infl ammatory drugs and concomi-
tant use of diuretics, angiotensin-converting enzyme inhibi-
tors, and angiotensin receptor blockers in arthroplasty popula-
tions is unclear (Lee et al. 2007, Fournier et al. 2014). Amino-
glycosides (such as gentamycin) that are used as intravenous 
antibiotic prophylaxis or in cement may trigger AKI because 
of their nephrotoxicity (Curtis et al. 2005, Patrick et al. 2006, 
Lau and Kumar 2013, Ross et al. 2013, Bell et al. 2014, Crax-
ford et al. 2014, Johansson et al. 2016) but otherwise, there 
are no data on the conditions or underlying reasons that trigger 
postoperative AKI in arthroplasty patients. 
We assessed the incidence and factors associated with AKI 
following hip and knee arthroplasty in a large Scandinavian 
cohort and report the specifi c conditions associated with 
AKI. We hypothesized that: (1) the Scandinavian population 
would have similar rates of AKI to those in other popula-
tions; and (2) the ASA classifi cation system (as a measure 
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of comorbidity) and duration of operation would show an 
association with AKI. 
Patients and methods
The study was performed in a large publicly funded orthope-
dic hospital specialized in joint replacement surgery, with an 
annual number of arthroplasties exceeding 3,000. The study 
population comprised patients with hip or knee arthroplas-
ties performed at the hospital between September 2002 and 
December 2011 (n = 20,575). 2,000 patients were excluded 
from the study (Figure 1). The remaining 18,575 patients were 
used for the analyses. Demographic data and patient informa-
tion were obtained from a prospective joint replacement data-
base and patient administration database. The following data 
were collected for analysis: sex, age, indication for operation, 
BMI, ASA classifi cation, anesthesia modality, prophylactic 
antibiotic, operated joint (hip or knee), duration of operation, 
fi xation method (cemented, cementless, hybrid), laterality 
(unilateral or bilateral operation), type of operation (primary 
or revision), and use of antibiotic-impregnated bone cement 
(Tables 1 and 2).
Pre- and postoperative serum creatinine (SCr) levels were 
obtained from the database of a local laboratory that provides 
our hospital, an adjacent university hospital, and the major-
ity of the communities in the catchment area with laboratory 
services. The SCr level is routinely obtained as part of the 
pre-anesthesia evaluation carried out 1–2 months before the 
operation, but measurements taken within 6 months before the 
operation were approved. If multiple preoperative SCr mea-
surements were recorded, the most recent SCr measurement 
was used. Postoperatively, SCr was measured for clinical indi-
cations only and not routinely. In our study, we took account 
of all postoperative SCr measurements taken ≤ 7 days after the 
operation, which was done in 5,609 operations (30%). These 
patients had lower eGFR preoperatively (76 mL/min/1.73 m2 
vs 87 mL/min/1.73 m2), older mean age (76 years vs 67 years), 
higher ASA classifi cation (median 3 vs. 2), and a slightly 
longer mean duration of operation (105 min vs. 100 min) than 
patients with no SCr measurement done during the fi rst 7 post-
operative days. Of these patients, 39% (2,210) were male and 
22% (1,222) had revision arthroplasty. There were also 5,361 
patients (29%) who lacked postoperative laboratory follow-
up after discharge from our unit because their home county 
used a different laboratory. We included these patients in our 
analysis to maximize the number of AKI cases and therefore 
to maximize statistical power. As the characteristics of these 
patients differed slightly from those of the patients who were 
examined in our laboratory (data not shown), we excluded 
these patients from the sensitivity analysis to eliminate a pos-
sible source of bias. 
We used SCr to classify all the patients into one of the 
RIFLE classifi cations (risk, injury, failure) or into a non-AKI 
group (Bellomo et al. 2007). We assumed that the patients 
who were not tested for postoperative SCr would not have had 
postoperative AKI. To maintain high specifi city, those patients 
who were in the risk of AKI class were classifi ed as not having 
AKI. We used preoperative SCr to calculate the estimated glo-
merular fi ltration rate (eGFR) using the CKD-EPI formula 
(Levey et al. 2009). 
In patients who developed AKI (class I or F according to the 
RIFLE criteria), we reviewed the medical records in order to 
defi ne the possible pre- and postoperative risk factors associ-
ated with AKI (Table 4), and the outcome of AKI. We clas-
sifi ed the outcome as spontaneous return of kidney function, 
loss of kidney function, or end-stage kidney disease. 
Statistics
For the statistical analyses, we identifi ed the AKI cases using 
the criteria described above. Furthermore, we used all the non-
AKI patients as a control group. 95% confi dence interval (CI) 
for the incidence rate of postoperative AKI was calculated 
using the Wilson score interval. The relationship between 
potential risk factors and AKI was analyzed using univari-
able binary logistic regression. Multivariable binary logistic 
regression analysis was performed using the enter method to 
minimize bias. To create a multivariable model, we used a 
directed acyclic graph (DAG) to establish a causal relationship 
between variables and to fi nd a minimal adjustment set to min-
imize bias. Due to the complexity of the causal relationships 
among all variables associated with AKI, we used the Dagitty 
tool (Textor et al. 2011) to create the multivariable model. We 
chose duration of operation as an exposure variable and AKI 
as an outcome variable. The Dagitty model showed that BMI, 
fi xation technique, bilateral operation, and operation type and 
joint was the minimal suffi cient adjustment set to minimize 
bias. We also included the ASA classifi cations and preopera-
tive eGFR in the multivariable model according to clinical 
experience (see Supplementary data) and because these vari-
ables were interesting for our study hypothesis. We performed 
a sensitivity analysis that included only the minimal adjust-
ment set to make sure that the results remained unchanged 
when the ASA classifi cations and eGFR were added to the 
model. A Kaplan-Meier analysis was performed to determine 
the effect of AKI on survival rates. The results were consid-
Analyzed (n = 18,575):
– primary arthroplasties, 15,943
– revision arthroplasties, 2,632
Eligible hip and knee arthroplasties 
September 2002 – December 2011
(n = 20,575)
Excluded (n = 2,000):
– lacking preoperative SCr, 1,031
– emergency operations, 969
Figure 1. Exclusion of patients.
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ered statistically signifi cant when the p-value was < 0.05. As 
the incidence of AKI is very low, all the odds ratios provided 
can be interpreted as relative risk (RR) unless otherwise stated. 
We used SPSS 21 software for the statistical analysis. 
Ethics
In Finland, ethical committee approval is not required in retro-
spective studies with no human subjects, such as this one. The 
study was accepted by Pirkanmaa hospital district (ETL-code 
13501) on Mar 1, 2013.
Funding and potential confl ict of interest
We are grateful for the fi nancial support for the project given 
by the Finnish Arthroplasty Association (Suomen Artroplas-
tiayhdistys) in 2012. No competing interests declared. 
Results
58 cases of AKI were identifi ed in 18,575 patients. Among 
the 13,214 patients whose specimens were tested by our hos-
pital laboratory, 44 AKI cases were identifi ed and the inci-
dence of AKI was 3.3 per 1,000 operations (95% CI: 2.5–
4.5). Of the 58 patients with AKI, 43 had injury- and 15 had 
failure-stage AKI. In univariable analysis, the risk factors for 
AKI preoperatively were age, BMI, ASA classifi cation, SCr, 
eGFR, and hemoglobin value (Table 1), and perioperatively 
the risk factors were operation type and intravenous antibi-
otic prophylaxis (Table 2). The multivariable model showed 
that duration of operation, ASA classifi cation, BMI, and pre-
operative eGFR were independent risk factors for postopera-
tive AKI (Table 3).
Table 1.  Association between preoperative factors and AKI; univariable regression results
     Incidence
     1,000 per
Descriptor All patients a AKI  non-AKI operations OR (95% CI) p-value
Age, median (range) 69 (14–102) 76 (41–88) 69 (14–102)  1.05 (1.02–1.08) 0.001
Sex      
 Female 11,650 (63) 33 11,617 2.8 Reference 
 Male 6,925 (37) 25   6,900 3.6 1.3 (0.76–2.1) 0.4
Body mass index 
  (missing, n = 1,719)
 median, (range) 28.6 (14–59) 31.6 (24–43) 28.6 (14–59)  1.1 (1.0–1.1) 0.001
 < 25 3,551 (21)   6   3,545 1.7 Reference 
 25–30 6,760 (40) 14   6,746 2.1 1.2 (0.47–3.2) 0.7
 30–35 4,496 (27) 14   4,482 3.1 1.9 (0.71–4.8) 0.2
    > 35 2,049 (12) 12   2,037 5.9 3.5 (1.3–9.3) 0.01
Joint      
 Hip 8,821 (47) 23   8,798 2.6 Reference 
 Knee 9,754 (53) 35   9,719 3.6 1.4 (0.8–2.3) 0.2
ASA classifi cation 
  (missing, n = 132)      
 1  1,477 (8)   0   1,477 0.0  
 2 8,427 (46)   9   8,418 1.1 Reference b < 0.001
 3 8,046 (44) 40   8,006 5.0 5.5 (2.7–11) < 0.001
 4 492 (3)   7      485 14.4 16 (5.9–43) < 0.001
Preoperative SCr 70 (25–1,125) 78 (49–150) 70 (25–1,125)  1.004 (1.00–1.01) 0.007
Preoperative eGFR, 
 median (range) c 85 (3–160) 68 (30–108) 85 (3–160)  0.97 (0.95–0.98) < 0.001
   1 (> 90 mL/min) 6,519 (35)   9   6,510 1.4 Reference 
   2 (60–89 mL/min) 9,917 (53) 29   9,888 2.9 2.1 (1.0–4.5) 0.05
   3 (30–59 mL/min) 2,023 (11) 19   2,004 9.4 6.9 (3.1–15) < 0.001
   4 (15–29 mL/min) 81 (0.4)   1        80 12.5 9.0 (1.1–72) 0.04
   5 (< 15 mL/min) 35 (0.2)   0        35 0 – –
Preoperative hemoglobin, 
  (missing, n = 72) 
 median (range) 138 (76–189) 135 (103–163) 138 (80–189)  0.97 (0.95–0.99) 0.001
Preoperative anemia d      
 No 16,423 (88) 47 16,376 2.9 Reference 
 Yes 2,080 (11) 11   2,069 5.3 1.9 (0.96–3.6) 0.07
Diagnosis       
 Primary osteoarthritis 15,467 (83) 47 15,420 3.0 Reference 
 Other diagnosis 3,073 (17) 10   3,063 3.3 1.1 (0.54–2.1) 0.8
a In this column, numbers mean number of patients and percentage in parentheses unless otherwise stated.
b
 ASA classes 1 and 2 were combined for the regression analysis.  
c
 eGFR calculated using CKD-EPI formula.
d Anemia was defi ned as hemoglobin < 117 g/L in women and < 134 g/L in men. 
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Sensitivity analysis was performed to determine whether 
these results were also valid in the primary arthroplasty group 
(n = 15,943). Multivariable analysis demonstrated the same 
independent risk factors for AKI as identifi ed in the original 
analysis. We also repeated the analysis with adjustment for 
only the variables in the minimal suffi cient adjustment set, and 
the results remained unchanged, confi rming that both duration 
of operation and BMI were independent risk factors for AKI. 
In the third sensitivity analysis, we excluded all 5,361 patients 
(14 of 58 AKI cases) with a different laboratory register in 
their community and thus possibly lacking a 7-day postop-
erative laboratory follow-up. This analysis showed the same 
independent risk factors for AKI. 
A potential cause of AKI was identifi ed in 28 cases. The 
most common conditions were postoperative infections in 15 
patients, cardiac causes in 5 patients, and pseudo-obstruction 
in 5 patients. In 28 cases, no specifi c cause could be identifi ed 
retrospectively. Most patients had several factors that possibly 
contributed to the development of AKI (Table 4). 2 of the AKI 
patients had no patient records concerning the postoperative 
period, so the reason for AKI could not be found. 2 patients 
with AKI underwent postoperative dialysis for less than 4 
weeks and both recovered their kidney function. Thus, neither 
of these patients was classifi ed in the loss of kidney function 
group or the end-stage kidney disease group. 
Mortality was substantially higher in AKI patients than in 
non-AKI patients throughout the follow-up (Figure 2).
Discussion
Despite the fact that preoperative kidney dysfunction accord-
ing to eGFR is common in our Scandinavian population (65% 
of the patients had eGFR < 90 mL/min), AKI is rare (with an 
incidence of 3.3 per 1,000 arthroplasties). We found that dura-
tion of operation, preoperative eGFR, ASA class, and BMI 
were all independent risk factors for postoperative AKI. How-
ever, half of all cases of AKI occurred without any underlying 
Table 2.  Association between perioperative factors and AKI; univariable regression results
    incidence
    per 1,000
Descriptor All patients a AKI  Non-AKI operations OR (95% CI) p-value
Operation type       
 Primary 15,943 (85) 44 15,899 2.8 Reference 
 Revision 2,632 (15) 14 2,618 5.3 1.9 (1.1–3.5) 0.03
Knee operation type       
 Unicondylar 607 (6) 1 606 1.7 Reference 
 Total 9,147 (94) 34 9,113 3.7 2.3 (0.31–17) 0.4
Bilateral operation       
 No 16,908 (91) 55 16,853 3.3 Ref 
 Yes 1,667 (9) 3 1,664 1.8 0.55 (0.17–1.8) 0.3
Prothesis fi xation method 
  (missing n = 1,410)       
 Cementless 4,107 (24) 6 4,101 1.4 Reference 0.2
 Hybrid 2,595 (15) 7 2,591 2.7 1.9 (0.62–5.5) 0.3
 Total cement 10,460 (61) 35 10,425 3.4 2.3 (0.96–5.5) 0.06
Use of antibiotic-impregnated bone cement 
  (missing, n = 589)       
 Gentamycin 11,764 (94) 40 11,724 3.4  
 Tobramycin 541 (4) 0 541 0  
 Other 164 (1) 0 164 0  
Antibiotic prophylaxis 
  (missing, n = 592)       
 Cefuroxime 17,714 (99) 48 17,666 2.7 Reference 0.005
 Clindamicin 207 (1) 3 204 14.7 5.4 (1.7–17) 0.005
 Other 62 (0.3) 1 61 16.4 6.0 (0.82–44) 0.08
Anesthesia modality 
  (missing, n = 105)       
 Spinal 2,077 (11) 4 2,073 1.9 Reference 0.8
 Continuous spinal 1,710 (9) 7 1,703 4.1 6.3 (0.66–61) 0.2
 Combined spinal epidural 14,302 (77) 44 14,258 3.1 3.0 (0.41–23) 0.4
 General 287 (2.0) 1 286 3.5 8.3 (0.52–133) 0.6
    Other 94 (0.5) 0 94 0  1
Duration of operation b 
  (missing, n = 110)
 median (range) 10 (10–68) 12 (6–25) 10 (10–68)  1.0 (1.0–1.1) 0.07
a In this column, numbers mean number of patients and percentage in parentheses unless otherwise stated.
b Duration in 10-min intervals (time from incision to end of wound closure).
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cause identifi ed. The survival of patients with AKI was worse 
than that of non-AKI patients.
The incidence of AKI was lower than that reported by other 
groups (3.3 per 1,000 vs. 5.5 per 1,000 vs. 52 per 1,000) 
(Jafari et al. 2010, Kimmel et al. 2014). This might be due to 
lower BMI (29 vs. 32 and 31), a smaller proportion of general 
anesthesia (1.5% vs. 6.1% and 60%), a larger proportion of 
ASA class 1 patients (8.0% vs. 4.8% and 2.8%), and shorter 
duration of operation (100 min vs 157 min vs 119 min) in 
our cohort compared to the other cohorts (Jafari et al. 2010, 
Kimmel et al. 2014). The incidence of AKI was lower com-
pared to Perregaard et al. 2016 (3.3 per 1,000 vs. 21.9 per 
1,000). Unlike in our study, they included mild-stage AKI in 
their analysis, which probably explains the difference.
We found that BMI was an independent risk factor for AKI, 
a fi nding supported by previous studies (Jafari et al. 2010. 
Kimmel et al. 2014). An association has also been shown 
between lower eGFR and AKI (Jafari et al. 2010, Kimmel et 
al. 2014, Bell et al. 2015). In univariable analysis, preopera-
tive renal impairment increased doubled the risk of AKI by 
2-fold, when eGFR was lower than 90 mL/min and increased 
it by 7-fold when eGFR was lower than 60mL/min. The indi-
dence of AKI was higher following revision than after primary 
surgery, but the association was lost in multivariable analysis, 
probably because revision arthroplasty patients had more fac-
tors associated with AKI. In our population, patients undergo-
ing revision arthroplasty generally had a longer duration of 
operation and a higher ASA class. 
Some case reports have suggested that vancomycin-, tobra-
mycin-, and gentamycin-impregnated bone cements may also 
induce AKI (Curtis et al. 2005, Patrick et al. 2006, Lau and 
Kumar 2013, Johansson et al. 2016). In our study, aminogly-
coside bone cement (94% gentamycin) was used in all patients 
and still we had a low rate of AKI. Furthermore, AKI rates 
were similar between cementless, hybrid, and fully cemented 
arthroplasties. 
Our study validates ASA class as an independent risk factor 
for AKI in arthroplasty patients. This is in accordance with 
cohorts comprising patients undergoing a large variety of 
orthopedic operations, including various arthroplasties, frac-
tures, and osteotomies (Bell et al. 2015). Previous studies on 
arthroplasty patients (Jafari et al. 2010, Kimmel et al. 2014) 
again included multiple morbidities in the multivariable model 
alongside the ASA class, which might explain why ASA class 
was not a signifi cant predictor of AKI in these studies. Our 
odds ratios in different ASA classes were high, and we suggest 
that readers should not interpret these results as relative risk. 
Table 3. Multivariable regression results
Descriptor OR (95% CI) p-value
Duration of operation a 1.1 (1.0–1.2) 0.003
ASA classifi cation   
 1 and 2 Reference 
    3 4.4 (1.8–11) 0.002
 4 13 (3.7–46) < 0.001
Bilaterality  
 Unilateral Reference 
 Bilateral 0.31 (0.06–1.6) 0.2
Body mass index 1.1 (1.0–1.1) 0.02
Fixation technique  
 Cementless Reference 
    Hybrid 1.7 (0.56–5.1) 0.3
 Total cement 1.2 (0.39–3.7) 0.8
Joint  
    Hip Ref 
 Knee 1.0 (0.43–2.5) 1
Operation type  
 Primary Reference 
     Revision 0.46 (0.12–1.7) 0.2
Preoperative eGFR b 0.98 (0.97–1.0) 0.03
a Duration in 10-min intervals (from incision to end of wound closure).
b eGFR calculated using CKD-EPI formula.
Table 4. Factors possibly contributing to development of AKI in 58 
patients
Risk factor Frequency (missing)
ASA class ≥ 3 47 (2)
Baseline BP ≤ 80 mmHg a 14 (4)
Blood transfusion 14 (5) 
BMI ≥ 30 26 (12) 
Duration ≥ 120 min 30 (2) 
eGFR ≤ 90 mL/min 49  
Medication combination b 10 (9) 
Perioperative NSAIDs 20 (9) 
Preoperative anemia c 11
Use of vasoactives d 22 (4) 
a
 Perioperative blood pressure.
b Concomitant use of 3 or more of the following drugs in periopera-
tive period: diuretics, angiotensin-converting enzyme inhibitors 
(ACEis) or angiotensin receptor blockers (ARBs), NSAIDs.
c Anemia was defi ned as hemoglobin < 117 g/L in women and 
 < 134 g/L in men.  
d Atropine or etilefrine.
Figure 2. Survival curve, with all-cause mortality as endpoint.
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We are the fi rst group to fi nd that duration of operation was a 
strong and independent risk factor for AKI. Other studies that 
have found an insignifi cant association between duration of 
operation and AKI were case-control studies with smaller con-
trol groups (Jafari et al. 2010, Kimmel et al. 2014) or smaller 
cohort studies (Weingarten et al. 2012). In our study popula-
tion, the incidence of AKI almost doubled when the duration 
of surgery exceeded 120 min. Clinical experience shows that 
prolonged surgery is usually caused by perioperative prob-
lems, and longer duration has plenty of associations with 
other perioperative factors (for example, blood transfusions, 
cooling, coagulopathies, and use of anesthetics) that could 
mediate AKI. However, the systemic infl ammation caused 
by increased tissue damage due to the prolonged duration of 
the operation and prolonged tourniquet use could also be the 
explanation (Andres et al. 2003, Basile et al. 2012). 
Concerning antibiotic prophylaxis, earlier studies have 
shown an association between gentamycin and AKI (Ross et 
al. 2013, Bell et al. 2014, Craxford et al. 2014, Johansson et 
al. 2016). In our cohort, gentamycin was rarely used. Instead 
of gentamycin, the secondary option for cefuroxime was 
clindamycin. However, in the AKI patients, only 3 patients 
received clindamycin, so signifi cant results in univariable anal-
ysis concerning clindamycin should be viewed with caution.
Whenever AKI occurred, its outcome was good—with only 
2 of the 58 AKI patients receiving dialysis, and neither of them 
for more than 4 weeks. This result is in accordance with the 
earlier literature. Jafari et al. (2010) reported that 7 out of 98 
of their AKI patients received dialysis, whereas Kimmel et al. 
(2014) reported that none of their AKI patients (AKI stage I or 
F, n = 22) received dialysis postoperatively. Although resolution 
of kidney function was common, the survival of patients with 
AKI was surprisingly poor, which warrants further research. 
In half of the cases, no specifi c cause or condition underly-
ing the AKI was found. It is possible that a triggering factor 
for AKI in these patients might simply be the systemic stress 
caused by the operation. Post- or preoperative infection, para-
lytic ileus, and cardiac causes were remarkable factors under-
lying AKI and served to explain almost half of the AKI cases. 
By preventing these factors, it might be possible to reduce 
rates of AKI. We do, however, acknowledge that in some cases 
the factors leading to AKI could not be identifi ed because of 
the retrospective nature of the study. 
The strength of the present study was the relatively large 
patient cohort compared to previous studies. We used a full, 
unselected cohort as controls in our analysis. Moreover, the 
underlying causes of AKI have not been adequately reported 
before. The study also had some limitations. Because the 
records of some patients were not available, there was a lack 
of information on the underlying reasons for their AKI. As 
SCr was measured for clinical indications and not routinely in 
all patients, it is probable that some AKI cases were not identi-
fi ed. Thus, it is likely that more AKI cases would have been 
found if the SCr of all patients had been screened every day 
during the fi rst postoperative week. In the earlier literature, not 
all postoperative SCr levels were recorded either (Jafari et al. 
2010), so the results are comparable. Kimmel et al. (2014) had 
postoperative SCr measured from every patient and reported 
remarkably higher rates of AKI than ours (52 per 1,000 vs. 3.3 
per 1,000). In our study population, the incidence of AKI in 
patients for whom postoperative SCr was measured was much 
smaller (10 per 1,000 operations), although this incidence 
number is probably overstated due to selection bias. 
In summary, we found that high rates of AKI might be pre-
vented if the risk profi le of patients is favorable. Contrary to 
our hypothesis, we found very low rates of AKI. The results 
suggest that the risk of developing AKI is elevated in patients 
with a duration of operation exceeding 120 min, higher BMI, 
ASA class ≥ 3, or impaired kidney function preoperatively 
(eGFR< 90 mL/min). We therefore suggest careful renal 
monitoring postoperatively for patients with these risk factors, 
in order to identify AKI. It is important to fi nd and optimize 
patients who are at risk of AKI already preoperatively, to pre-
vent future kidney manifestations—and also to communicate 
the risk to the patient when considering a procedure aimed at 
improving quality of life in a high-risk patient. 
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